TNF and inflammatory bowel disease: Anti-inflammatory approaches, such as tumor necrosis factor (TNF) inhibitors, blocking antibodies against the interleukin (IL)-6 pathway, and Janus kinase inhibitors, have been actively evaluated to determine their efficacy in IBD treatment.